Corporate Profile

TransCode Therapeutics is an emerging RNA oncology company committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics. TransCode’s proprietary platform, TTX, repurposes an iron oxide nanoparticle that has been extensively used for imaging to solve for RNA delivery in oncology. Leveraging this novel delivery system, TransCode deploys a modular toolbox to design and develop a broad pipeline of product candidates intended to safely and efficiently deliver therapeutic oligonucleotides to their intended genetic targets in tumors and metastases.

Stock Quote